Literature DB >> 35461318

Microbiota in health and diseases.

Kaijian Hou1, Zhuo-Xun Wu2, Xuan-Yu Chen2, Jing-Quan Wang2, Dongya Zhang3, Chuanxing Xiao1, Dan Zhu1, Jagadish B Koya2, Liuya Wei4, Jilin Li5, Zhe-Sheng Chen6.   

Abstract

The role of microbiota in health and diseases is being highlighted by numerous studies since its discovery. Depending on the localized regions, microbiota can be classified into gut, oral, respiratory, and skin microbiota. The microbial communities are in symbiosis with the host, contributing to homeostasis and regulating immune function. However, microbiota dysbiosis can lead to dysregulation of bodily functions and diseases including cardiovascular diseases (CVDs), cancers, respiratory diseases, etc. In this review, we discuss the current knowledge of how microbiota links to host health or pathogenesis. We first summarize the research of microbiota in healthy conditions, including the gut-brain axis, colonization resistance and immune modulation. Then, we highlight the pathogenesis of microbiota dysbiosis in disease development and progression, primarily associated with dysregulation of community composition, modulation of host immune response, and induction of chronic inflammation. Finally, we introduce the clinical approaches that utilize microbiota for disease treatment, such as microbiota modulation and fecal microbial transplantation.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 35461318      PMCID: PMC9034083          DOI: 10.1038/s41392-022-00974-4

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN: 2059-3635


  408 in total

Review 1.  CRISPR-Cas adaptation: insights into the mechanism of action.

Authors:  Gil Amitai; Rotem Sorek
Journal:  Nat Rev Microbiol       Date:  2016-01-11       Impact factor: 60.633

2.  Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents.

Authors:  Azucena Perez-Burgos; Bingxian Wang; Yu-Kang Mao; Bhavik Mistry; Karen-Anne McVey Neufeld; John Bienenstock; Wolfgang Kunze
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-11-08       Impact factor: 4.052

Review 3.  Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression.

Authors:  Karen D Corbin; Steven H Zeisel
Journal:  Curr Opin Gastroenterol       Date:  2012-03       Impact factor: 3.287

4.  Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study.

Authors:  Isabel Leiva-Gea; Lidia Sánchez-Alcoholado; Beatriz Martín-Tejedor; Daniel Castellano-Castillo; Isabel Moreno-Indias; Antonio Urda-Cardona; Francisco J Tinahones; José Carlos Fernández-García; María Isabel Queipo-Ortuño
Journal:  Diabetes Care       Date:  2018-09-17       Impact factor: 19.112

5.  Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals.

Authors:  Christine M Bassis; John R Erb-Downward; Robert P Dickson; Christine M Freeman; Thomas M Schmidt; Vincent B Young; James M Beck; Jeffrey L Curtis; Gary B Huffnagle
Journal:  MBio       Date:  2015-03-03       Impact factor: 7.867

Review 6.  The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease.

Authors:  Lucrezia Laterza; Gianenrico Rizzatti; Eleonora Gaetani; Patrizia Chiusolo; Antonio Gasbarrini
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-05-01       Impact factor: 2.576

7.  Gut microbiome alterations in Alzheimer's disease.

Authors:  Nicholas M Vogt; Robert L Kerby; Kimberly A Dill-McFarland; Sandra J Harding; Andrew P Merluzzi; Sterling C Johnson; Cynthia M Carlsson; Sanjay Asthana; Henrik Zetterberg; Kaj Blennow; Barbara B Bendlin; Federico E Rey
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

8.  Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study.

Authors:  Xiaofei Qi; Xuewei Li; Ye Zhao; Xiaojin Wu; Feng Chen; Xiao Ma; Faming Zhang; Depei Wu
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

Review 9.  Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review.

Authors:  He Zhou; Xue Zhao; Lin Sun; Yujia Liu; You Lv; Xiaokun Gang; Guixia Wang
Journal:  Dis Markers       Date:  2020-08-27       Impact factor: 3.434

10.  Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project.

Authors:  Zongxin Ling; Xia Liu; Yiwen Cheng; Xiawei Jiang; Haiyin Jiang; Yuezhu Wang; Lanjuan Li
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

View more
  12 in total

1.  Gut microbes regulate the feeding center: a new discovery of Gut Brain Axis.

Authors:  Fengwu Chen; Kaijian Hou; Zhe-Sheng Chen
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

Review 2.  Probiotics: Protecting Our Health from the Gut.

Authors:  Gael Urait Varela-Trinidad; Carolina Domínguez-Díaz; Karla Solórzano-Castanedo; Liliana Íñiguez-Gutiérrez; Teresita de Jesús Hernández-Flores; Mary Fafutis-Morris
Journal:  Microorganisms       Date:  2022-07-14

3.  Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease.

Authors:  Rongping Chen; Dan Zhu; Rui Yang; Zezhen Wu; Ningning Xu; Fengwu Chen; Shuo Zhang; Hong Chen; Ming Li; Kaijian Hou
Journal:  Ann Transl Med       Date:  2022-07

4.  Chitosan Oligosaccharide Attenuates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction through Suppressing the Inflammatory Response and Oxidative Stress in Mice.

Authors:  Wenjing Tao; Geng Wang; Xun Pei; Wanjing Sun; Minqi Wang
Journal:  Antioxidants (Basel)       Date:  2022-07-17

Review 5.  Microbial dysbiosis and childhood asthma development: Integrated role of the airway and gut microbiome, environmental exposures, and host metabolic and immune response.

Authors:  Conglin Liu; Heidi Makrinioti; Sejal Saglani; Michael Bowman; Lih-Ling Lin; Carlos A Camargo; Kohei Hasegawa; Zhaozhong Zhu
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

Review 6.  Dietary Polysaccharides as Modulators of the Gut Microbiota Ecosystem: An Update on Their Impact on Health.

Authors:  Ana I Álvarez-Mercado; Julio Plaza-Diaz
Journal:  Nutrients       Date:  2022-10-03       Impact factor: 6.706

7.  Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus.

Authors:  Lina He; Rongping Chen; Bangzhou Zhang; Shuo Zhang; Barkat Ali Khan; Dan Zhu; Zezhen Wu; Chuanxing Xiao; Baolong Chen; Fengwu Chen; Kaijian Hou
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

8.  Exercise Interventions Improved Sleep Quality through Regulating Intestinal Microbiota Composition.

Authors:  Liangwu Qiu; Fuhong Gong; Jiang Wu; Dingyun You; Yinzhou Zhao; Lianwu Xu; Xue Cao; Fukai Bao
Journal:  Int J Environ Res Public Health       Date:  2022-09-28       Impact factor: 4.614

Review 9.  Regulatory effects of marine polysaccharides on gut microbiota dysbiosis: A review.

Authors:  Jieying Ou; Zhuo Wang; Xiaofei Liu; Bingbing Song; Jianping Chen; Rui Li; Xuejing Jia; Riming Huang; Wenzhou Xiang; Saiyi Zhong
Journal:  Food Chem X       Date:  2022-09-09

10.  Oral microbiota in oropharyngeal cancers: Friend or foe?

Authors:  Riccardo Nocini; Lorenzo Lo Muzio; Davide Gibellini; Giovanni Malerba; Michele Milella; Salvatore Chirumbolo; Nicoletta Zerman
Journal:  Front Oncol       Date:  2022-09-13       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.